1. The latest crowdfunder to support David Tuller's work has opened. To donate click here.
    Dismiss Notice
  2. Guest, the two part 'News in Brief' for the week beginning 11th October 2021 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31. 2020, Pothineni et al

Discussion in 'Infections: Lyme, Candida, EBV ...' started by Andy, Mar 19, 2020.

  1. Andy

    Andy Committee Member (& Outreach when energy allows)

    Hampshire, UK
    Open access, https://www.nature.com/articles/s41598-020-59600-4
    dadouv47, shak8, alktipping and 3 others like this.
  2. 5vforest

    5vforest Senior Member (Voting Rights)

    San Francisco, CA
    There are a lot of people suffering from chronic Lyme Disease who are banking on Azlocillin being a silver bullet cure. I am pretty skeptical.

    I am really unclear as to why Azlocillin was chosen in this study, besides the fact that the researchers have a patent for its reformulation into an oral drug.

    There are probably a lot of compounds that will eradicate Bb in vitro. Remember, Disulfiram was said to do this as well, and it's already available for use. But there are a lot of people who remain sick, with some evidence of persistent infection, despite a course of Dilsulfiram.

    There are a lot of remaining questions for those of us suffering with chronic effects of tick borne infections and I am dubious that Azlocillin is going to change much.

Share This Page